|
|
|
|
| LEADER |
02023nam a22004215i 4500 |
| 001 |
978-3-319-20741-4 |
| 003 |
DE-He213 |
| 005 |
20151204143147.0 |
| 007 |
cr nn 008mamaa |
| 008 |
151015s2015 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319207414
|9 978-3-319-20741-4
|
| 024 |
7 |
|
|a 10.1007/978-3-319-20741-4
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC254-282
|
| 072 |
|
7 |
|a MJCL
|2 bicssc
|
| 072 |
|
7 |
|a MED062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.994
|2 23
|
| 100 |
1 |
|
|a Cappuzzo, Federico.
|e author.
|
| 245 |
1 |
0 |
|a Guide to Targeted Therapies: Treatment Resistance in Lung Cancer
|h [electronic resource] /
|c by Federico Cappuzzo.
|
| 250 |
|
|
|a 1st ed. 2015.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Adis,
|c 2015.
|
| 300 |
|
|
|a VII, 67 p. 14 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a Introduction -- Therapy options for advanced NSCLC -- Resistance to EGFR TKIs -- Overcoming EGFR-TKI resistance -- Resistance to crizotinib and therapeutic options -- Resistance to angiogenic drugs and therapeutics options.- Conclusions.
|
| 520 |
|
|
|a This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319207407
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-319-20741-4
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
